New test predicts immune effector cell-associated neurotoxicity syndrome
Medical researchers in Japan have discovered a way to predict immune effector cell-associated neurotoxicity syndrome,…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
New study explores the link between diet, blood sugar and cancer risk across species
Researchers have long known that diet exerts a profound influence on health, including the risk…
Exercise key to improving sexual dysfunction for patients with prostate cancer
New research from Edith Cowan University (ECU), Australia, has confirmed that erectile dysfunction in patients…
The secret DNA circles fueling pancreatic cancer’s aggression
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of…
Rethinking breast cancer screening: new insights on overdiagnosis
A new editorial, “COMET gazing—interesting insights, lessons for clinical practice, and a call for more…
Transforming thymic carcinoma treatment with a dual approach
Thymic epithelial tumours are a rare group of malignancies originating in the thymus gland, that…
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing…
ELF4: A key transcription factor shaping immunity and cancer progression
ELF4, a transcription factor belonging to the ETS family, has emerged as a pivotal regulator…
Unveiling the role of tumour-infiltrating immune cells in endometrial carcinoma
A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through…
Prostate cancer is not a death knell, study shows
Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024.1.4 million new cases worldwide…